93 related articles for article (PubMed ID: 9388269)
41. Differences in the characteristics of inhibition of lymphocyte stimulation by 25-hydroxycholesterol and by the immunoregulatory serum lipoprotein LDL-In.
Curtiss LK; Edgington TS
J Immunol; 1980 Oct; 125(4):1470-4. PubMed ID: 7410845
[TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.
Westerterp M; Van Eck M; de Haan W; Offerman EH; Van Berkel TJ; Havekes LM; Rensen PC
Atherosclerosis; 2007 Nov; 195(1):e9-16. PubMed ID: 17320883
[TBL] [Abstract][Full Text] [Related]
43. Quality control of protein C: protein C synthesized in the presence of warfarin is selectively degraded in the endoplasmic reticulum.
Koide T; Tokunaga F; Wakabayashi S
Pol J Pharmacol; 1996; 48(2):203-7. PubMed ID: 9112652
[TBL] [Abstract][Full Text] [Related]
44. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice.
Auger A; Truong TQ; Rhainds D; Lapointe J; Letarte F; Brissette L
Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750
[TBL] [Abstract][Full Text] [Related]
45. The cell and molecular biology of apolipoprotein E synthesis by macrophages.
Werb Z; Chin JR; Takemura R; Oropeza RL; Bainton DF; Stenberg P; Taylor JM; Reardon C
Ciba Found Symp; 1986; 118():155-71. PubMed ID: 3525037
[TBL] [Abstract][Full Text] [Related]
46. Endogenously expressed apolipoprotein E has different effects on cell lipid metabolism as compared to exogenous apolipoprotein E carried on triglyceride-rich particles.
Ho YY; Al-Haideri M; Mazzone T; Vogel T; Presley JF; Sturley SL; Deckelbaum RJ
Biochemistry; 2000 Apr; 39(16):4746-54. PubMed ID: 10769131
[TBL] [Abstract][Full Text] [Related]
47. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
48. Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis.
Rensen PC; Jong MC; van Vark LC; van der Boom H; Hendriks WL; van Berkel TJ; Biessen EA; Havekes LM
J Biol Chem; 2000 Mar; 275(12):8564-71. PubMed ID: 10722695
[TBL] [Abstract][Full Text] [Related]
49. Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes.
Zhu MY; Hasty AH; Harris C; Linton MF; Fazio S; Swift LL
Metabolism; 2005 Oct; 54(10):1309-15. PubMed ID: 16154429
[TBL] [Abstract][Full Text] [Related]
50. A pathway-dependent on apoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells.
Yancey PG; Yu H; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1123-31. PubMed ID: 17303773
[TBL] [Abstract][Full Text] [Related]
51. Regulation of endogenous apolipoprotein E secretion by macrophages.
Kockx M; Jessup W; Kritharides L
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1060-7. PubMed ID: 18388328
[TBL] [Abstract][Full Text] [Related]
52. Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.
Van Eck M; Van Dijk KW; Herijgers N; Hofker MH; Groot PH; Van Berkel TJ
Atherosclerosis; 2001 Jan; 154(1):103-12. PubMed ID: 11137088
[TBL] [Abstract][Full Text] [Related]
53. Sterol carrier protein-2 overexpression enhances sterol cycling and inhibits cholesterol ester synthesis and high density lipoprotein cholesterol secretion.
Baum CL; Reschly EJ; Gayen AK; Groh ME; Schadick K
J Biol Chem; 1997 Mar; 272(10):6490-8. PubMed ID: 9045674
[TBL] [Abstract][Full Text] [Related]
54. Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow.
Van Eck M; Herijgers N; Vidgeon-Hart M; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Atherosclerosis; 2000 May; 150(1):71-80. PubMed ID: 10781637
[TBL] [Abstract][Full Text] [Related]
55. The effect of 25-hydroxycholesterol on the regulation of apolipoprotein E mRNA levels and secretion in the human hepatoma HepG2.
Tam SP; Ramharack R
Atherosclerosis; 1992 Aug; 95(2-3):137-46. PubMed ID: 1329783
[TBL] [Abstract][Full Text] [Related]
56. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
[TBL] [Abstract][Full Text] [Related]
57. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.
Bellosta S; Mahley RW; Sanan DA; Murata J; Newland DL; Taylor JM; Pitas RE
J Clin Invest; 1995 Nov; 96(5):2170-9. PubMed ID: 7593602
[TBL] [Abstract][Full Text] [Related]
58. Oleate potentiates oxysterol inhibition of transcription from sterol regulatory element-1-regulated promoters and maturation of sterol regulatory element-binding proteins.
Thewke DP; Panini SR; Sinensky M
J Biol Chem; 1998 Aug; 273(33):21402-7. PubMed ID: 9694903
[TBL] [Abstract][Full Text] [Related]
59. Effect of atorvastatin on ApoE and ApoC-I synthesis and secretion by THP-1 macrophages.
Castilho LN; Chamberland A; Boulet L; Davignon J; Cohn JS; Bernier L
J Cardiovasc Pharmacol; 2003 Aug; 42(2):251-7. PubMed ID: 12883330
[TBL] [Abstract][Full Text] [Related]
60. Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.
Basu SK; Brown MS; Ho YK; Havel RJ; Goldstein JL
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7545-9. PubMed ID: 6950395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
